Cervical cancer prevention for all the world's women: Genuine promise resides in skilled quality management rather than novel screening approaches

Eric J. Suba, Amber D Donnelly, Lisa M. Furia, My Linh D Huynh, Stephen S. Raab

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

The debate over the best route for cervical cancer prevention in developing countries may be considered part of a larger debate over whether the global health community has become enamored with the promise of new approaches at the expense of delivering available preventives today. Pap screening, which is feasible anywhere cervical screening is appropriate, is the only intervention currently available for the prevention of cervical cancer in developing countries, and the Pap test will be an essential component of future novel preventive approaches. Cervical cancer vaccination, the long-term effectiveness of which is uncertain, will not eliminate screening requirements and is currently not affordable in developing countries. Root cause analyses, which may appropriately inform the best routes for improving health in developing countries, document that failures of cervical cancel-prevention efforts are not attributable to factors specific to the Pap test but to lapses in programmatic quality management to which all screening tests are vulnerable. The genuine promise of cervical cancer prevention for all the world's women therefore resides in skilled quality management rather than novel screening approaches. We propose a global consensus policy by which Pap screening services will be provided in any setting where cervical screening is appropriate but unavailable, with consideration given to novel preventive approaches as they mature. Opportunity costs, borne by the underserved, are associated with prioritizing research on new approaches in any setting where established preventives are feasible but unavailable.

Original languageEnglish (US)
Pages (from-to)187-191
Number of pages5
JournalDiagnostic cytopathology
Volume35
Issue number3
DOIs
StatePublished - Mar 1 2007

Fingerprint

Uterine Cervical Neoplasms
Developing Countries
Papanicolaou Test
Root Cause Analysis
Vaccination
Costs and Cost Analysis
Health
Research

Keywords

  • Bill and Melinda Gates Foundation
  • Cervical cancer prevention
  • Developing countries
  • Quality management

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Histology

Cite this

Cervical cancer prevention for all the world's women : Genuine promise resides in skilled quality management rather than novel screening approaches. / Suba, Eric J.; Donnelly, Amber D; Furia, Lisa M.; Huynh, My Linh D; Raab, Stephen S.

In: Diagnostic cytopathology, Vol. 35, No. 3, 01.03.2007, p. 187-191.

Research output: Contribution to journalArticle

@article{13b31fcfe3944e7c932fc5a29399426e,
title = "Cervical cancer prevention for all the world's women: Genuine promise resides in skilled quality management rather than novel screening approaches",
abstract = "The debate over the best route for cervical cancer prevention in developing countries may be considered part of a larger debate over whether the global health community has become enamored with the promise of new approaches at the expense of delivering available preventives today. Pap screening, which is feasible anywhere cervical screening is appropriate, is the only intervention currently available for the prevention of cervical cancer in developing countries, and the Pap test will be an essential component of future novel preventive approaches. Cervical cancer vaccination, the long-term effectiveness of which is uncertain, will not eliminate screening requirements and is currently not affordable in developing countries. Root cause analyses, which may appropriately inform the best routes for improving health in developing countries, document that failures of cervical cancel-prevention efforts are not attributable to factors specific to the Pap test but to lapses in programmatic quality management to which all screening tests are vulnerable. The genuine promise of cervical cancer prevention for all the world's women therefore resides in skilled quality management rather than novel screening approaches. We propose a global consensus policy by which Pap screening services will be provided in any setting where cervical screening is appropriate but unavailable, with consideration given to novel preventive approaches as they mature. Opportunity costs, borne by the underserved, are associated with prioritizing research on new approaches in any setting where established preventives are feasible but unavailable.",
keywords = "Bill and Melinda Gates Foundation, Cervical cancer prevention, Developing countries, Quality management",
author = "Suba, {Eric J.} and Donnelly, {Amber D} and Furia, {Lisa M.} and Huynh, {My Linh D} and Raab, {Stephen S.}",
year = "2007",
month = "3",
day = "1",
doi = "10.1002/dc.20575",
language = "English (US)",
volume = "35",
pages = "187--191",
journal = "Diagnostic Cytopathology",
issn = "8755-1039",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Cervical cancer prevention for all the world's women

T2 - Genuine promise resides in skilled quality management rather than novel screening approaches

AU - Suba, Eric J.

AU - Donnelly, Amber D

AU - Furia, Lisa M.

AU - Huynh, My Linh D

AU - Raab, Stephen S.

PY - 2007/3/1

Y1 - 2007/3/1

N2 - The debate over the best route for cervical cancer prevention in developing countries may be considered part of a larger debate over whether the global health community has become enamored with the promise of new approaches at the expense of delivering available preventives today. Pap screening, which is feasible anywhere cervical screening is appropriate, is the only intervention currently available for the prevention of cervical cancer in developing countries, and the Pap test will be an essential component of future novel preventive approaches. Cervical cancer vaccination, the long-term effectiveness of which is uncertain, will not eliminate screening requirements and is currently not affordable in developing countries. Root cause analyses, which may appropriately inform the best routes for improving health in developing countries, document that failures of cervical cancel-prevention efforts are not attributable to factors specific to the Pap test but to lapses in programmatic quality management to which all screening tests are vulnerable. The genuine promise of cervical cancer prevention for all the world's women therefore resides in skilled quality management rather than novel screening approaches. We propose a global consensus policy by which Pap screening services will be provided in any setting where cervical screening is appropriate but unavailable, with consideration given to novel preventive approaches as they mature. Opportunity costs, borne by the underserved, are associated with prioritizing research on new approaches in any setting where established preventives are feasible but unavailable.

AB - The debate over the best route for cervical cancer prevention in developing countries may be considered part of a larger debate over whether the global health community has become enamored with the promise of new approaches at the expense of delivering available preventives today. Pap screening, which is feasible anywhere cervical screening is appropriate, is the only intervention currently available for the prevention of cervical cancer in developing countries, and the Pap test will be an essential component of future novel preventive approaches. Cervical cancer vaccination, the long-term effectiveness of which is uncertain, will not eliminate screening requirements and is currently not affordable in developing countries. Root cause analyses, which may appropriately inform the best routes for improving health in developing countries, document that failures of cervical cancel-prevention efforts are not attributable to factors specific to the Pap test but to lapses in programmatic quality management to which all screening tests are vulnerable. The genuine promise of cervical cancer prevention for all the world's women therefore resides in skilled quality management rather than novel screening approaches. We propose a global consensus policy by which Pap screening services will be provided in any setting where cervical screening is appropriate but unavailable, with consideration given to novel preventive approaches as they mature. Opportunity costs, borne by the underserved, are associated with prioritizing research on new approaches in any setting where established preventives are feasible but unavailable.

KW - Bill and Melinda Gates Foundation

KW - Cervical cancer prevention

KW - Developing countries

KW - Quality management

UR - http://www.scopus.com/inward/record.url?scp=33847613463&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33847613463&partnerID=8YFLogxK

U2 - 10.1002/dc.20575

DO - 10.1002/dc.20575

M3 - Article

C2 - 17304532

AN - SCOPUS:33847613463

VL - 35

SP - 187

EP - 191

JO - Diagnostic Cytopathology

JF - Diagnostic Cytopathology

SN - 8755-1039

IS - 3

ER -